VenaSeal™ Procedure ISI
Indications for Use
The VenaSeal™ closure system (VenaSeal™ system) is indicated for use in the permanent closure of lower extremity superficial truncal veins, such as the great saphenous vein (GSV), through endovascular embolization with coaptation. The VenaSeal system is intended for use in adults with clinically symptomatic venous reflux as diagnosed by duplex ultrasound (DUS).
Contraindications
Separate use of the individual components of the VenaSeal closure system is contraindicated. These components must be used as a system. The use of the VenaSeal system is contraindicated when any of the following conditions exist: previous hypersensitivity reactions to the VenaSeal adhesive or cyanoacrylates, acute superficial thrombophlebitis, thrombophlebitis migrans, acute sepsis.
Warnings
- The VenaSeal system is not designed for use in the coronary and cerebral vasculature, pulmonary vasculature, or diseased and atherosclerotic arteries.
- Do not flush the catheter with saline or fluid as this will make it unusable with the VenaSeal adhesive.
- Confirm position of the catheter tip in the desired location by ultrasound imaging before activation of the device.
- Injection of the VenaSeal adhesive should be done by hand injection only and using the VenaSeal delivery system provided. Do not use a power injector.
- Use the introducer in the VenaSeal delivery system for access to the peripheral vasculature. Failure to use the introducer for access may result in damage to the vessel, or failure of the VenaSeal system to perform as intended.
Precautions
- Verify that the VenaSeal adhesive is a clear and free-flowing liquid prior to use. Adhesive that is discolored should be discarded.
- The VenaSeal adhesive is intended to be delivered via the VenaSeal delivery system components only.
Potential Adverse Effects
The potential complications include, but are not limited to the following: adverse reactions to a foreign body (including, but not limited to, nonspecific mild inflammation of the cutaneous and subcutaneous tissue), arteriovenous fistula, bleeding from the access site, deep vein thrombosis (DVT), edema in the treated leg, embolization, including pulmonary embolism (PE), hematoma, hyperpigmentation, hypersensitivity or allergic reactions to cyanoacrylates, such as urticaria, shortness of breath, and anaphylactic shock, infection at the access site, pain, paresthesia, phlebitis, superficial thrombophlebitis, urticaria, erythema, or ulceration may occur at the injection site, vascular rupture and perforation, visible scarring.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
Important information: Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device, at medtronic.com/manuals or contact a Medtronic representative.
US-CV-2601075 v1.0